Cochrane Abstracts
Neo‐adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neo‐adjuvant and Adjuvant Hormone Therapy for Localised and Locally Advanced Prostate Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433796/all/Neo‐adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer.
Neo‐adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433796/all/Neo‐adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer. Accessed January 19, 2025.
Neo‐adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433796/all/Neo‐adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer
Neo‐adjuvant and Adjuvant Hormone Therapy for Localised and Locally Advanced Prostate Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433796/all/Neo‐adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neo‐adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
ID - 433796
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433796/all/Neo‐adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
